129 related articles for article (PubMed ID: 11352977)
1. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test.
Redgrave TG; Watts GF; Martins IJ; Barrett PH; Mamo JC; Dimmitt SB; Marais AD
J Lipid Res; 2001 May; 42(5):710-5. PubMed ID: 11352977
[TBL] [Abstract][Full Text] [Related]
2. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity.
Watts GF; Chan DC; Barrett PH; Martins IJ; Redgrave TG
Clin Sci (Lond); 2001 Dec; 101(6):683-90. PubMed ID: 11724657
[TBL] [Abstract][Full Text] [Related]
4. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test.
Chan DC; Watts GF; Barrett PH; Martins IJ; James AP; Mamo JC; Mori TA; Redgrave TG
J Lipid Res; 2002 May; 43(5):706-12. PubMed ID: 11971941
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity.
Chan DC; Watts GF; Mori TA; Barrett PH; Redgrave TG; Beilin LJ
Am J Clin Nutr; 2003 Feb; 77(2):300-7. PubMed ID: 12540386
[TBL] [Abstract][Full Text] [Related]
6. Measurement of expired carbon dioxide to assess the metabolism of remnant lipoproteins.
Redgrave TG; Martins IJ; Mortimer B-C
J Lipid Res; 1995 Dec; 36(12):2670-5. PubMed ID: 8847493
[TBL] [Abstract][Full Text] [Related]
7. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus.
Dane-Stewart CA; Watts GF; Barrett PH; Stuckey BG; Mamo JC; Martins IJ; Redgrave TG
Clin Endocrinol (Oxf); 2003 Apr; 58(4):415-20. PubMed ID: 12641623
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of chylomicron-like emulsions in patients with Hodgkin's and with non-Hodgkin's lymphoma.
Gonçalves RP; Hungria VT; Chiattone CS; Pozzi DB; Maranhão RC
Leuk Res; 2003 Feb; 27(2):147-53. PubMed ID: 12526920
[TBL] [Abstract][Full Text] [Related]
9. Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test.
Watts GF; Barrett PH; Marais AD; Dane-Stewart CA; Martins IJ; Dimmitt SB; Redgrave TG
Atherosclerosis; 2001 Aug; 157(2):519-23. PubMed ID: 11472755
[TBL] [Abstract][Full Text] [Related]
10. Relative roles of mitochondrial and peroxisomal fatty acid oxidation in the metabolism of chylomicron remnants in rats and mice as assessed by a stable-isotope breath test.
Martins IJ; Vermeulen R; Redgrave TG
Atherosclerosis; 2000 May; 150(1):13-20. PubMed ID: 10781631
[TBL] [Abstract][Full Text] [Related]
11. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of chylomicrons in patients with congenital lipoatrophic diabetes: a study with emulsion models of chylomicrons.
Wajchenberg BL; Amâncio RF; Santomauro AT; Maranhão RC
Clin Endocrinol (Oxf); 2004 Sep; 61(3):347-52. PubMed ID: 15355451
[TBL] [Abstract][Full Text] [Related]
13. Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia.
Dane-Stewart CA; Watts GF; Mamo JC; Barrett PH; Martins IJ; Dimmitt SB; Redgrave TG
Eur J Clin Invest; 2002 Jul; 32(7):493-9. PubMed ID: 12153549
[TBL] [Abstract][Full Text] [Related]
14. Chylomicron metabolism is markedly altered in systemic lupus erythematosus.
Borba EF; Bonfá E; Vinagre CG; Ramires JA; Maranhão RC
Arthritis Rheum; 2000 May; 43(5):1033-40. PubMed ID: 10817556
[TBL] [Abstract][Full Text] [Related]
15. Features of cholesterol structure that regulate the clearance of chylomicron-like lipid emulsions.
Mortimer BC; Tso P; Phan CT; Beveridge DJ; Wen J; Redgrave TG
J Lipid Res; 1995 Sep; 36(9):2038-53. PubMed ID: 8558091
[TBL] [Abstract][Full Text] [Related]
16. Competition between chylomicrons and their remnants for plasma removal: a study with artificial emulsion models of chylomicrons.
Oliveira HC; Hirata MH; Redgrave TG; Maranhão RC
Biochim Biophys Acta; 1988 Feb; 958(2):211-7. PubMed ID: 3337836
[TBL] [Abstract][Full Text] [Related]
17. Effect of pravastatin on plasma removal of a chylomicron-like emulsion in men with coronary artery disease.
Santos RD; Sposito AC; Ventura LI; Cesar LA; Ramires JA; Maranhão RC
Am J Cardiol; 2000 May; 85(10):1163-6. PubMed ID: 10801994
[TBL] [Abstract][Full Text] [Related]
18. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
Bowler A; Redgrave TG; Mamo JC
Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
[TBL] [Abstract][Full Text] [Related]
19. Food restriction normalizes chylomicron remnant metabolism in murine models of obesity as assessed by a novel stable isotope breath test.
Martins IJ; Tran JM; Redgrave TG
J Nutr; 2002 Feb; 132(2):176-81. PubMed ID: 11823575
[TBL] [Abstract][Full Text] [Related]
20. A 13CO2 breath test to assess the metabolism of triglyceride-rich lipoprotein remnants in mice.
Martins IJ; Redgrave TG
J Lipid Res; 1998 Mar; 39(3):691-8. PubMed ID: 9548600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
